HtrA Serine Peptidase 4 (HTRA4) Peptid
Kurzübersicht für HtrA Serine Peptidase 4 (HTRA4) Peptid (ABIN940477)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- LKMHYPDFPD VSSGVYVCKV VEGTAAQSSG LRDHDVIVNI NGKPITTTTD
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HTRA4 antibody,
Alternative Names: HTRA4 control peptide, HTRA4 antibody Blocking Peptide, Anti-HTRA4 Blocking Peptide, Htra Serine Peptidase 4 Blocking Peptide, FLJ90724 Blocking Peptide -
Aufreinigung
- Immunoaffinity chromatography.
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- HTRA4 (HtrA Serine Peptidase 4 (HTRA4))
-
Hintergrund
- HTRA4 is a member of the HtrA family of proteases. The protein contains a putative signal peptide, an insulin growth factor binding domain, a Kazal protease inhibitor domain, a conserved trypsin domain and a PDZ domain. Based on studies on other related family members, this enzyme may function as a secreted oligomeric chaperone protease to degrade misfolded secretory proteins. Other human HtrA proteins have been implicated in arthritis, tumor suppression, unfolded stress response, apoptosis, and aging.
-
Molekulargewicht
- 51 kDa
Target
-